OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

Disseminated histoplasmosis in the Americas – a lethal blind spot of health organisations

Posted .

The global health tragedy that is avoidable deaths from histoplasmosis, has been highlighted in the current edition of the Journal AIDS (AIDS 2016, 30:167–170). Despite a burden of ~1,600,000 HIV patients in South and Central America, most hospitals have no access to rapid diagnostic techniques and often lack the right treatment. Histoplasma capsulatum is endemic and… Read more »

Read more >

World’s first clinical guidelines for chronic fungal lung infections

Posted .

The world’s first guidelines for CPA have been published in the European Respiratory Journal by the ERS in conjunction with ESCMID. The guidelines cover the important features of this disease & comprehensive treatment and recommendations  for chronic pulmonary aspergillosis (CPA). This disease is fatal in about 80% of sufferers who succumb to this illness when their lungs… Read more »

Read more >

First new antifungal agent – isavuconazole – launched since 2006

Posted .

This week, Isavuconazole (Cresemba) will become available in Europe for the first time, following its recent launch in the USA. This is the first new antifungal agent launched for 9 years. It has a broad spectrum, intravenous and oral formulations, is required only once daily and a very good safety profile. Following the FDA approval… Read more »

Read more >

Histoplasmosis – the leading AIDS diagnosis in the Guiana Shield and parts of central America

Posted .

  At the first ‘Histoplasmosis in the Americas and the Caribbean Meeting’ in Paramaribo Suriname, representatives from Latin America shared the dramatic problems of disseminated histoplasmosis in AIDS. The histoplasmosis problem exceeds the TB problem in many regions, and dwarfs malaria (<100 deaths annually across the Americas). One in 3 or 4 new AIDS admissions… Read more »

Read more >

World AIDS Day – progress towards the ’95-95 by 2025’ goals

Posted .

In May 2015, GAFFI issued a call to reduce AIDS deaths to under 500,000 by 2020 by provision of fungal diagnostics and antifungal therapies (GAFFI Roadmap).  In conjunction with increasing antiretroviral therapy coverage (90-90-90-  meaning action on fungal diseases will achieve a million more HIV survivors each year by 2020), diagnostics are also required for… Read more »

Read more >

Burden of fungal diseases in 636 million people in 15 countries now published

Posted .

In the Journal Mycoses, Denning and 47 co-authors from across the world have estimated the number of people affected by serious  fungal diseases in a population of 636 million in 15 countries: Belgium, Czech Republic, Denmark, Hungary, Nepal, Qatar, Tanzania, Trinidad and Tobago, Uganda, Germany, Mexico, Senegal, Tanzania, Ukraine, Vietnam. These estimates have never been attempted… Read more »

Read more >

UN 2030 Agenda for Sustainable Development – with much-needed support for reducing the impact of non-communicable diseases

Posted .

On 25th September, the UN formally adopted its 17 sustainable development goals (SDGs) and 169 targets for 2030. These goals build on and expand the Millennium Development Goals (MDG), and integrate the economic, social and environmental aspects of sustainable development. Non Communicable Diseases (NCDs) along with other major risk factors are linked to several of… Read more »

Read more >